Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Advanced Solid Tumours
×
capivasertib
×
Clear all
Filters
3
NCT04742036
2022-08-19
Capivasertib China PK Study
AstraZeneca
Phase 1
Completed
16 enrolled